Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 9.86B 1.46B 1.28B 1.18B 1.09B 2.04B 140B 2.09B 14.09B 5.53B 68.84B 5.47B 5.35B 237B P/E 2026 *
97.5x
P/E 2027 * 74.5x
Enterprise Value 9.86B 1.46B 1.28B 1.18B 1.09B 2.04B 140B 2.09B 14.09B 5.53B 68.84B 5.47B 5.35B 237B EV / Sales 2026 *
9.05x
EV / Sales 2027 * 7.97x
Free-Float
64.5%
Yield 2026 *
-
Yield 2027 * -
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-07 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-15 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-04 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
29/09/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. completed the acquisition of 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd. CI
09/09/25 Shandong Linuo Pharmaceutical Packaging's shareholder to unload shares RE
1 day-6.61%
1 week-23.98%
Current month-43.17%
1 month-39.80%
3 months+63.11%
6 months+108.33%
Current year+116.02%
1 week 37.68
Extreme 37.68
45.5
1 month 37.68
Extreme 37.68
76.3
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 15/04/2024
Director of Finance/CFO 45 29/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 68 31/10/2025
Director/Board Member 77 15/04/2024
Director/Board Member 60 15/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-6.61%-23.98%+85.19%+146.72% 1.56B
+0.44%+2.60%-0.58%+19.17% 3.64B
-1.57%-0.99%-29.18%-43.50% 2.74B
-1.00%+3.01%-14.58%-29.35% 1.86B
-5.21%-2.15%-36.98%-59.88% 1.47B
0.00%+5.75%-10.24%-52.16% 761M
+0.49%+0.59%+71.12%+54.83% 590M
-3.55%-9.79%+28.43%+30.24% 578M
-2.07%+3.17%-39.87%-55.26% 473M
+0.38%-0.96%+119.77%+120.44% 386M
Average -1.87%+0.72%+17.31%+13.13% 1.41B
Weighted average by Cap. -1.79%+0.56%+3.36%+4.78%

Financials

2026 *2027 *
Net sales 1.09B 161M 141M 130M 120M 225M 15.51B 231M 1.56B 611M 7.61B 605M 592M 26.15B 1.24B 183M 160M 148M 136M 256M 17.61B 262M 1.77B 694M 8.64B 687M 672M 29.7B
Net income 103M 15.22M 13.33M 12.3M 11.33M 21.3M 1.47B 21.8M 147M 57.78M 719M 57.15M 55.89M 2.47B 137M 20.24M 17.73M 16.36M 15.07M 28.33M 1.95B 29M 196M 76.85M 956M 76.02M 74.35M 3.29B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
17/07/26 CN¥38.02 -6.61% 14,554,293
16/07/26 CN¥40.71 -3.83% 12,190,761
15/07/26 CN¥42.33 -2.64% 14,325,640
14/07/26 CN¥43.48 +5.53% 16,206,330
13/07/26 CN¥41.20 -9.91% 25,142,173

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock